{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:10:28Z","timestamp":1786374628118,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503881"],"award-info":[{"award-number":["82503881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M772151"],"award-info":[{"award-number":["2025M772151"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henan Provincial International Training Program for High-Level Talents","award":["GCC2025043"],"award-info":[{"award-number":["GCC2025043"]}]},{"name":"Henan Provincial People\u2019s Hospital through the Doctor Startup Fund","award":["ZC20250047"],"award-info":[{"award-number":["ZC20250047"]}]},{"name":"Henan Medical Researcher Overseas Training Program","award":["HNMOT2025004"],"award-info":[{"award-number":["HNMOT2025004"]}]},{"name":"the Henan Province \u201cThree 100\u201d Plan Task Document: Henan Medical Researcher Overseas Training Program","award":["HNMOT2025004"],"award-info":[{"award-number":["HNMOT2025004"]}]},{"name":"the Science and Technology Research Project of Henan Provincial Health Commission: Exploration of the Application of a Novel Patient-Specific Breast Cancer Vaccine in Cancer Immunotherapy","award":["232102310051"],"award-info":[{"award-number":["232102310051"]}]},{"name":"the Key Project of the Henan Province Medical Science and Technology Research Plan","award":["SBGJ202502016, SBGJ202502017"],"award-info":[{"award-number":["SBGJ202502016, SBGJ202502017"]}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102311054"],"award-info":[{"award-number":["252102311054"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04440-1","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:27:12Z","timestamp":1780583232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged S-adenosylmethionine exposure is associated with poorer treatment response and adverse outcomes in breast cancer: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiaru","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqiang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"4440_CR1","doi-asserted-by":"publisher","first-page":"658552","DOI":"10.3389\/fonc.2021.658552","volume":"11","author":"J Cao","year":"2021","unstructured":"Cao J, Zhang M, Wang B, et al. Chemoresistance and metastasis in breast cancer molecular mechanisms and novel clinical strategies. Front Oncol. 2021;11:658552.","journal-title":"Front Oncol"},{"issue":"1","key":"4440_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s44178-022-00007-8","volume":"1","author":"J Wu","year":"2022","unstructured":"Wu J, Fan D, Shao Z, et al. CACA guidelines for holistic integrative management of breast cancer. Holist Integr Oncol. 2022;1(1):7.","journal-title":"Holist Integr Oncol"},{"key":"4440_CR3","doi-asserted-by":"publisher","first-page":"1047684","DOI":"10.3389\/fonc.2022.1047684","volume":"12","author":"CY Lin","year":"2022","unstructured":"Lin CY, Hsiao SY, Huang WT, et al. Incidence of second primary malignancies in women with different stages of breast cancer. Front Oncol. 2022;12:1047684.","journal-title":"Front Oncol"},{"issue":"5","key":"4440_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/pharmaceutics17050657","volume":"17","author":"R Valsalakumari","year":"2025","unstructured":"Valsalakumari R, Feith M, Pettersen S, et al. Combinatorial effects of free and nanoencapsulated forms of cabazitaxel and RAS-selective lethal 3 in breast cancer cells. Pharmaceutics. 2025;17(5):657.","journal-title":"Pharmaceutics"},{"issue":"10","key":"4440_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/apt.18271","volume":"60","author":"A Fettiplace","year":"2024","unstructured":"Fettiplace A, Marcinak J, Merz M, et al. Review article: recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients. Aliment Pharmacol Ther. 2024;60(10):1293\u2013307.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"4440_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12072-023-10633-7","volume":"18","author":"Y Mao","year":"2024","unstructured":"Mao Y, Ma S, Liu C, et al. Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update. Hepatol Int. 2024;18(2):384\u2013419.","journal-title":"Hepatol Int"},{"key":"4440_CR7","doi-asserted-by":"publisher","first-page":"100974","DOI":"10.1016\/j.drup.2023.100974","volume":"69","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Shen H, Xu J, et al. GATA3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells. Drug Resist Updates: Rev Comment Antimicrob Anticancer Chemother. 2023;69:100974.","journal-title":"Drug Resist Updates: Rev Comment Antimicrob Anticancer Chemother"},{"issue":"8","key":"4440_CR8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41418-022-00939-8","volume":"29","author":"L Yuan","year":"2022","unstructured":"Yuan L, Li S, Chen Q, et al. EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ. 2022;29(8):1513\u201327.","journal-title":"Cell Death Differ"},{"issue":"19","key":"4440_CR9","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.3390\/molecules27196717","volume":"27","author":"J Wang","year":"2022","unstructured":"Wang J, Tian T, Li X, et al. Noncoding RNAs emerging as drugs or drug targets: their chemical modification, bio-conjugation and intracellular regulation. Mol (Basel Switz). 2022;27(19):6717.","journal-title":"Mol (Basel Switz)"},{"key":"4440_CR10","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/s41467-018-04426-y","volume":"9","author":"Z Dai","year":"2018","unstructured":"Dai Z, Mentch SJ, Gao X, et al. Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat Commun. 2018;9:1955.","journal-title":"Nat Commun"},{"issue":"1","key":"4440_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12943-022-01680-z","volume":"21","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zou H, Dang Q, et al. Biological and pharmacological roles of m6A modifications in cancer drug resistance. Mol Cancer. 2022;21(1):220.","journal-title":"Mol Cancer"},{"issue":"6","key":"4440_CR12","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.jaci.2021.12.783","volume":"149","author":"L Fu","year":"2022","unstructured":"Fu L, Zhao J, Huang J, et al. A mitochondrial STAT3-methionine metabolism axis promotes ILC2-driven allergic lung inflammation. J Allergy Clin Immunol. 2022;149(6):2091\u2013104.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4440_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-021-02200-5","volume":"41","author":"L Ma","year":"2022","unstructured":"Ma L, Xue X, Zhang X, et al. The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma. J exp clin cancer res: CR. 2022;41(1):36.","journal-title":"J exp clin cancer res: CR"},{"issue":"5","key":"4440_CR14","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1002\/ctm2.778","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, He J, Sun G, et al. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin Transl Med. 2022;12(5):e778.","journal-title":"Clin Transl Med"},{"issue":"6","key":"4440_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222\u201361.","journal-title":"J Hepatol"},{"issue":"1","key":"4440_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, et al. Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies. Actas Dermosifiliogr (Engl Ed). 2021;112(1):90\u20132.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"5","key":"4440_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw: JNCCN. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Cancer Netw: JNCCN"},{"issue":"12","key":"4440_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/bjs.11300","volume":"106","author":"E Heeg","year":"2019","unstructured":"Heeg E, Harmeling JX, Becherer BE, et al. Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy. Br J Surg [Internet]. 2019;106(12):1640\u20138.","journal-title":"Br J Surg [Internet]"},{"issue":"2","key":"4440_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (Oxf Engl: 1990). 2009;45(2):228\u201347.","journal-title":"Eur J Cancer (Oxf Engl: 1990)"},{"issue":"1","key":"4440_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-020-00349-7","volume":"5","author":"Z Li","year":"2020","unstructured":"Li Z, Wang F, Liang B, et al. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct Target Ther. 2020;5(1):280.","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"4440_CR21","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.3390\/nu16213668","volume":"16","author":"KER Baden","year":"2024","unstructured":"Baden KER, McClain H, Craig E, et al. S-adenosylmethionine (SAMe) for liver health: a systematic review. Nutrients. 2024;16(21):3668.","journal-title":"Nutrients"},{"issue":"6D","key":"4440_CR22","first-page":"5173","volume":"23","author":"D Santini","year":"2003","unstructured":"Santini D, Vincenzi B, Massacesi C, et al. S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury. Anticancer Res. 2003;23(6D):5173\u20139.","journal-title":"Anticancer Res"},{"issue":"14","key":"4440_CR23","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3748\/wjg.v22.i14.3746","volume":"22","author":"SA Lozano-Sepulveda","year":"2016","unstructured":"Lozano-Sepulveda SA, Bautista-Osorio E, Merino-Mascorro JA, et al. S-adenosyl-L-methionine modifies antioxidant-enzymes, glutathione-biosynthesis and methionine adenosyltransferases-1\/2 in hepatitis C virus-expressing cells. World J Gastroenterol. 2016;22(14):3746\u201357.","journal-title":"World J Gastroenterol"},{"key":"4440_CR24","doi-asserted-by":"publisher","first-page":"100720","DOI":"10.1016\/j.drup.2020.100720","volume":"53","author":"B Li","year":"2020","unstructured":"Li B, Jiang J, Assaraf YG, et al. Surmounting cancer drug resistance: new insights from the perspective of N6-methyladenosine RNA modification. Drug Resist Updates: Rev Comment Antimicrob Anticancer Chemother. 2020;53:100720.","journal-title":"Drug Resist Updates: Rev Comment Antimicrob Anticancer Chemother"},{"issue":"1","key":"4440_CR25","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, et al. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12(1):1786.","journal-title":"Nat Commun"},{"issue":"46","key":"4440_CR26","first-page":"e2401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci (Weinh Baden-Wurtt Ger). 2024;11(46):e2401399.","journal-title":"Adv Sci (Weinh Baden-Wurtt Ger)"},{"issue":"2","key":"4440_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2024.10.017","volume":"37","author":"K Lin","year":"2025","unstructured":"Lin K, Wei L, Wang R, et al. Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1. Cell Metab. 2025;37(2):460\u2013e4768.","journal-title":"Cell Metab"},{"issue":"9","key":"4440_CR28","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1039\/D2NP00086E","volume":"40","author":"YH Lee","year":"2023","unstructured":"Lee YH, Ren D, Jeon B, et al. S-adenosylmethionine: more than just a methyl donor. Nat Prod Rep. 2023;40(9):1521\u201349.","journal-title":"Nat Prod Rep"},{"issue":"1","key":"4440_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s43018-023-00671-3","volume":"5","author":"F Li","year":"2024","unstructured":"Li F, Liu P, Mi W, et al. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer. Nat Cancer. 2024;5(1):131\u201346.","journal-title":"Nat Cancer"},{"key":"4440_CR30","doi-asserted-by":"publisher","first-page":"1451971","DOI":"10.3389\/freae.2024.1451971","volume":"2","author":"T Bernasocchi","year":"2024","unstructured":"Bernasocchi T, Mostoslavsky R. Subcellular one carbon metabolism in cancer, aging and epigenetics. Front Epigenetics Epigenomics. 2024;2:1451971.","journal-title":"Front Epigenetics Epigenomics"},{"issue":"15","key":"4440_CR31","first-page":"e2415207","volume":"12","author":"B Su","year":"2025","unstructured":"Su B, Chen Q, Li X, et al. A methionine allocation nanoregulator for the suppression of cancer stem cells and support to the immune cells by epigenetic regulation. Adv Sci (Weinh Baden-Wurtt Ger). 2025;12(15):e2415207.","journal-title":"Adv Sci (Weinh Baden-Wurtt Ger)"},{"issue":"2","key":"4440_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.gene.2016.09.032","volume":"595","author":"T Schmidt","year":"2016","unstructured":"Schmidt T, Leha A, Salinas-Riester G. Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles. Gene. 2016;595(2):161\u20137.","journal-title":"Gene"},{"issue":"8","key":"4440_CR33","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.cmet.2025.05.014","volume":"37","author":"Z Chen","year":"2025","unstructured":"Chen Z, Gu X, Chen H, et al. RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation. Cell Metab. 2025;37(8):1732\u2013e17499.","journal-title":"Cell Metab"},{"issue":"3","key":"4440_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/gutjnl-2022-326928","volume":"72","author":"T Li","year":"2023","unstructured":"Li T, Tan YT, Chen YX, et al. Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts. Gut. 2023;72(3):501\u201311.","journal-title":"Gut"},{"issue":"1","key":"4440_CR35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41419-025-08045-6","volume":"16","author":"Y Tan","year":"2025","unstructured":"Tan Y, Zhou C, Bian S, et al. The RNA N6-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling. Cell Death Dis. 2025;16(1):804.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4440_CR36","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Li H, Hu D, et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer. 2022;21(1):32.","journal-title":"Mol Cancer"},{"issue":"2","key":"4440_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/JAD-170177","volume":"58","author":"Q Li","year":"2017","unstructured":"Li Q, Cui J, Fang C, et al. S-adenosylmethionine attenuates oxidative stress and neuroinflammation induced by amyloid-\u03b2 through modulation of glutathione metabolism. J Alzheimer\u2019s dis: JAD. 2017;58(2):549\u201358.","journal-title":"J Alzheimer\u2019s dis: JAD"},{"issue":"1","key":"4440_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12957-024-03626-9","volume":"22","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Gao J, Jia L, et al. Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis. World J Surg Oncol. 2024;22(1):345.","journal-title":"World J Surg Oncol"},{"issue":"5","key":"4440_CR39","doi-asserted-by":"publisher","first-page":"e0149","DOI":"10.1097\/HC9.0000000000000149","volume":"7","author":"JY Kwak","year":"2023","unstructured":"Kwak JY, Kim HG, Han JH, et al. Association of the etiology and peak level of markedly elevated aminotransferases with mortality: a multicenter study. Hepatol Commun. 2023;7(5):e0149.","journal-title":"Hepatol Commun"},{"issue":"8","key":"4440_CR40","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/curroncol32080441","volume":"32","author":"K Yanagihara","year":"2025","unstructured":"Yanagihara K, Yoshida M, Yamakawa T, et al. Efficacy and safety of dose-dense chemotherapy in breast cancer: real clinical data and literature review. Curr Oncol (Tor Ont). 2025;32(8):441.","journal-title":"Curr Oncol (Tor Ont)"},{"issue":"3","key":"4440_CR41","first-page":"343","volume":"19","author":"H Ye","year":"2021","unstructured":"Ye H, Chen T, Zeng Z, et al. The m6A writers regulated by the IL-6\/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma. Cancer Biol Med. 2021;19(3):343\u201357.","journal-title":"Cancer Biol Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04440-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:03:12Z","timestamp":1786370592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04440-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4440"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04440-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Zhengzhou University People\u2019s Hospital. All patients or their families provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that all authors have read and approved the manuscript, and that there are no other persons who satisfied the criteria for authorship but are not listed. We also confirm that the order of the authors listed in the manuscript has been approved by all of us.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"327"}}